KA
SNY icon

Kozak & Associates’s Sanofi SNY Stock Holding History

Kozak & Associates’s Portfolio SNY Stock Details SNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.83K Hold
92
– – ﹤0.01% 328
2026
Q1 		$4.32K Hold
92
– – ﹤0.01% 326
2025
Q4 		$4.51K Hold
92
– – ﹤0.01% 314
2025
Q3 		$4.76K Buy
+92
New +$4.44K ﹤0.01% 313

Other funds holding SNY

DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return
QCM
QRG Capital Management Chicago, Illinois $12.1B AUM 44.98% 1-Year Est. Return
MFG
Merit Financial Group Alpharetta, Georgia $16.4B AUM 25.17% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
TNB
Thomasville National Bank Thomasville, Georgia $1.82B AUM
SIS
Sound Income Strategies Ft Lauderdale, Florida $2.23B AUM 11.22% 1-Year Est. Return
FBT
First Bank & Trust Brookings, South Dakota $680M AUM 25.36% 1-Year Est. Return
FB
Fulton Bank Lancaster, Pennsylvania $3.27B AUM 17.38% 1-Year Est. Return
CAMG
CWA Asset Management Group Naples, Florida $3.28B AUM 34.07% 1-Year Est. Return
Envestnet Portfolio Solutions
Envestnet Portfolio Solutions Chicago, Illinois $20.9B AUM 19.34% 1-Year Est. Return

Kozak & Associates's SNY Position: Q2 2026 in Review

Kozak & Associates held its Sanofi (SNY) position steady in Q2 2026 at 92 shares worth $3.83K. The position accounts for ﹤0.01% of the portfolio, ranked #328.

Kozak & Associates first reported a position in SNY in Q3 2025 and has held it in 4 quarters since. The position peaked at $4.76K in Q3 2025. 109 funds tracked by Wall St. Rank hold SNY as of Q2 2026.

  • Kozak & Associates held 92 shares of Sanofi worth $3.83K as of Q2 2026.
  • Kozak & Associates left its Sanofi share count unchanged in Q2 2026.
  • Sanofi made up ﹤0.01% of Kozak & Associates's portfolio in Q2 2026, its #328 holding.
  • Kozak & Associates first reported a position in Sanofi in Q3 2025 and has held it in 4 quarters since.
  • Kozak & Associates's Sanofi position peaked at $4.76K in Q3 2025.
  • 109 funds tracked by Wall St. Rank held Sanofi as of Q2 2026.

Based on Kozak & Associates's 13F filing for Q2 2026, filed 2 Jul 2026.